Cancer Incidence Among Canadian Kidney Transplant Recipients
A number of studies have observed increased cancer incidence rates among individuals who have received renal transplants. Generally, however, these studies have been limited by relatively small sample sizes, short follow‐up intervals or focused on only one cancer site. We conducted a nationwide popu...
Saved in:
Published in | American journal of transplantation Vol. 7; no. 4; pp. 941 - 948 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.04.2007
Blackwell |
Subjects | |
Online Access | Get full text |
ISSN | 1600-6135 1600-6143 |
DOI | 10.1111/j.1600-6143.2007.01736.x |
Cover
Loading…
Abstract | A number of studies have observed increased cancer incidence rates among individuals who have received renal transplants. Generally, however, these studies have been limited by relatively small sample sizes, short follow‐up intervals or focused on only one cancer site. We conducted a nationwide population‐based study of 11,155 patients who underwent kidney transplantation between 1981 and 1998. Incident cancers were identified up to December 31, 1999, through record linkage to the Canadian Cancer Registry. Patterns of cancer incidence in the cohort were compared to the Canadian general population using standardized incidence ratios (SIRs). We examined variations in risk according time since transplantation, year of transplantation and age at transplantation. In our patient population, we observed a total of 778 incident cancers versus 313.2 expected (SIR = 2.5, 95% CI = 2.3–2.7). Site‐specific SIRs were highest for cancer of the lip (SIR = 31.3, 95% CI = 23.5–40.8), non‐Hodgkin's lymphoma (NHL) (SIR = 8.8, 95% CI = 7.4–10.5), and kidney cancer (SIR = 7.3, 95% CI = 5.7–9.2). SIRs for NHL and cancer of the lip and kidney were highest and among transplant patients. This study confirms previous findings of increased risks of posttransplant cancer. Our findings underscore the need for increased vigilance among kidney transplant recipients for cancers at sites where there are no population‐based screening programs in place.
This nationwide study of cancer risk in kidney transplant patients found a standardized incidence ratio of 2.5 compared to expected rates. |
---|---|
AbstractList | A number of studies have observed increased cancer incidence rates among individuals who have received renal transplants. Generally, however, these studies have been limited by relatively small sample sizes, short follow‐up intervals or focused on only one cancer site. We conducted a nationwide population‐based study of 11,155 patients who underwent kidney transplantation between 1981 and 1998. Incident cancers were identified up to December 31, 1999, through record linkage to the Canadian Cancer Registry. Patterns of cancer incidence in the cohort were compared to the Canadian general population using standardized incidence ratios (SIRs). We examined variations in risk according time since transplantation, year of transplantation and age at transplantation. In our patient population, we observed a total of 778 incident cancers versus 313.2 expected (SIR = 2.5, 95% CI = 2.3–2.7). Site‐specific SIRs were highest for cancer of the lip (SIR = 31.3, 95% CI = 23.5–40.8), non‐Hodgkin's lymphoma (NHL) (SIR = 8.8, 95% CI = 7.4–10.5), and kidney cancer (SIR = 7.3, 95% CI = 5.7–9.2). SIRs for NHL and cancer of the lip and kidney were highest and among transplant patients. This study confirms previous findings of increased risks of posttransplant cancer. Our findings underscore the need for increased vigilance among kidney transplant recipients for cancers at sites where there are no population‐based screening programs in place.
This nationwide study of cancer risk in kidney transplant patients found a standardized incidence ratio of 2.5 compared to expected rates. A number of studies have observed increased cancer incidence rates among individuals who have received renal transplants. Generally, however, these studies have been limited by relatively small sample sizes, short follow-up intervals or focused on only one cancer site. We conducted a nationwide population-based study of 11,155 patients who underwent kidney transplantation between 1981 and 1998. Incident cancers were identified up to December 31, 1999, through record linkage to the Canadian Cancer Registry. Patterns of cancer incidence in the cohort were compared to the Canadian general population using standardized incidence ratios (SIRs). We examined variations in risk according time since transplantation, year of transplantation and age at transplantation. In our patient population, we observed a total of 778 incident cancers versus 313.2 expected (SIR = 2.5, 95% CI = 2.3-2.7). Site-specific SIRs were highest for cancer of the lip (SIR = 31.3, 95% CI = 23.5-40.8), non-Hodgkin's lymphoma (NHL) (SIR = 8.8, 95% CI = 7.4-10.5), and kidney cancer (SIR = 7.3, 95% CI = 5.7-9.2). SIRs for NHL and cancer of the lip and kidney were highest and among transplant patients. This study confirms previous findings of increased risks of posttransplant cancer. Our findings underscore the need for increased vigilance among kidney transplant recipients for cancers at sites where there are no population-based screening programs in place. A number of studies have observed increased cancer incidence rates among individuals who have received renal transplants. Generally, however, these studies have been limited by relatively small sample sizes, short follow-up intervals or focused on only one cancer site. We conducted a nationwide population-based study of 11,155 patients who underwent kidney transplantation between 1981 and 1998. Incident cancers were identified up to December 31, 1999, through record linkage to the Canadian Cancer Registry. Patterns of cancer incidence in the cohort were compared to the Canadian general population using standardized incidence ratios (SIRs). We examined variations in risk according time since transplantation, year of transplantation and age at transplantation. In our patient population, we observed a total of 778 incident cancers versus 313.2 expected (SIR = 2.5, 95% CI = 2.3-2.7). Site-specific SIRs were highest for cancer of the lip (SIR = 31.3, 95% CI = 23.5-40.8), non-Hodgkin's lymphoma (NHL) (SIR = 8.8, 95% CI = 7.4-10.5), and kidney cancer (SIR = 7.3, 95% CI = 5.7-9.2). SIRs for NHL and cancer of the lip and kidney were highest and among transplant patients. This study confirms previous findings of increased risks of posttransplant cancer. Our findings underscore the need for increased vigilance among kidney transplant recipients for cancers at sites where there are no population-based screening programs in place.A number of studies have observed increased cancer incidence rates among individuals who have received renal transplants. Generally, however, these studies have been limited by relatively small sample sizes, short follow-up intervals or focused on only one cancer site. We conducted a nationwide population-based study of 11,155 patients who underwent kidney transplantation between 1981 and 1998. Incident cancers were identified up to December 31, 1999, through record linkage to the Canadian Cancer Registry. Patterns of cancer incidence in the cohort were compared to the Canadian general population using standardized incidence ratios (SIRs). We examined variations in risk according time since transplantation, year of transplantation and age at transplantation. In our patient population, we observed a total of 778 incident cancers versus 313.2 expected (SIR = 2.5, 95% CI = 2.3-2.7). Site-specific SIRs were highest for cancer of the lip (SIR = 31.3, 95% CI = 23.5-40.8), non-Hodgkin's lymphoma (NHL) (SIR = 8.8, 95% CI = 7.4-10.5), and kidney cancer (SIR = 7.3, 95% CI = 5.7-9.2). SIRs for NHL and cancer of the lip and kidney were highest and among transplant patients. This study confirms previous findings of increased risks of posttransplant cancer. Our findings underscore the need for increased vigilance among kidney transplant recipients for cancers at sites where there are no population-based screening programs in place. |
Author | Jiang, Y. Mao, Y. Villeneuve, P. J. Schaubel, D. E. Shepherd, F. A. Fenton, S. S. |
Author_xml | – sequence: 1 givenname: P. J. surname: Villeneuve fullname: Villeneuve, P. J. – sequence: 2 givenname: D. E. surname: Schaubel fullname: Schaubel, D. E. – sequence: 3 givenname: S. S. surname: Fenton fullname: Fenton, S. S. – sequence: 4 givenname: F. A. surname: Shepherd fullname: Shepherd, F. A. – sequence: 5 givenname: Y. surname: Jiang fullname: Jiang, Y. – sequence: 6 givenname: Y. surname: Mao fullname: Mao, Y. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18701504$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17331115$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkV9PwyAUxYnR6Db9CqYv-rZ6gQI1UZNl8c_UxMTMZ0KBGpaOztLF7dtL3dTEF-WFE_jdw72cPtr1tbcIJRhSHNfZLMUcYMhxRlMCIFLAgvJ0tYN63xe735qyA9QPYQaRIjnZRweRptGH9dDFWHltm2TitTM2ymQ0r_1rEo-VcconD854u06mjfJhUSnfJs9Wu4Wzvg2HaK9UVbBH232AXm6up-O74ePT7WQ8ehzqTOR8WGBFLVNClConGSu4ICU15xQTXhqtAWe6JAw010SDKYhhEQCmeJFnBgShA3S68V009dvShlbOXdC2iu3YehmkAAq5oOxPkEBGCCcdeLwFl8XcGrlo3Fw1a_n1MRE42QIqaFWVcXztwg-XC8AMssjlG043dQiNLX8QkF1Wcia7GGQXieyykp9ZyVUsvfpVql2rWlf7tlGu-o_B5cbg3VV2_e-H5eh-2in6ATZiqpE |
CitedBy_id | crossref_primary_10_3389_fped_2017_00008 crossref_primary_10_1002_cam4_3636 crossref_primary_10_1016_j_jss_2024_09_019 crossref_primary_10_1016_j_semnephrol_2023_151348 crossref_primary_10_1093_ndt_gfq017 crossref_primary_10_1158_1055_9965_EPI_09_0278 crossref_primary_10_3109_10428194_2011_557453 crossref_primary_10_1016_j_heliyon_2024_e32822 crossref_primary_10_1016_j_lungcan_2020_07_020 crossref_primary_10_1093_carcin_bgw053 crossref_primary_10_1016_j_transproceed_2008_12_013 crossref_primary_10_1016_j_bbmt_2010_03_007 crossref_primary_10_1002_ijc_24741 crossref_primary_10_1111_ajt_14368 crossref_primary_10_14338_IJPT_19_00067_1 crossref_primary_10_1007_s00256_024_04848_4 crossref_primary_10_1159_000343395 crossref_primary_10_13105_wjma_v11_i7_317 crossref_primary_10_1007_s11255_013_0544_6 crossref_primary_10_1016_j_canep_2010_07_002 crossref_primary_10_1111_j_1600_0714_2011_01072_x crossref_primary_10_1016_j_ejim_2023_09_010 crossref_primary_10_1097_TP_0000000000003773 crossref_primary_10_18632_oncotarget_23841 crossref_primary_10_1016_j_ijid_2012_08_002 crossref_primary_10_1016_j_transproceed_2015_04_053 crossref_primary_10_18632_oncotarget_13124 crossref_primary_10_1080_2090598X_2023_2225315 crossref_primary_10_1186_s12882_018_1110_3 crossref_primary_10_3389_fonc_2022_1017498 crossref_primary_10_1016_j_amjcard_2008_10_026 crossref_primary_10_1097_MCG_0000000000000880 crossref_primary_10_1016_j_surg_2010_07_016 crossref_primary_10_1007_s11560_008_0273_5 crossref_primary_10_1016_j_trre_2016_12_001 crossref_primary_10_1111_tri_13734 crossref_primary_10_1007_s00345_015_1758_2 crossref_primary_10_3390_jcm10214810 crossref_primary_10_1016_S1762_0953_10_52713_4 crossref_primary_10_18632_oncotarget_19456 crossref_primary_10_1016_j_clgc_2018_10_005 crossref_primary_10_1016_j_trre_2018_07_001 crossref_primary_10_1093_ndt_gfz026 crossref_primary_10_1016_j_tpr_2024_100158 crossref_primary_10_1111_ctr_13669 crossref_primary_10_1097_MNH_0b013e3282f06bba crossref_primary_10_1016_j_bjoms_2024_02_008 crossref_primary_10_1016_j_ejca_2012_09_013 crossref_primary_10_2215_CJN_14570920 crossref_primary_10_1038_bjc_2014_44 crossref_primary_10_1002_hed_25937 crossref_primary_10_2515_therapie_2013023 crossref_primary_10_1111_tid_12931 crossref_primary_10_3390_jcm13071872 crossref_primary_10_1111_j_1600_6143_2009_02973_x crossref_primary_10_1111_j_1600_6143_2009_02728_x crossref_primary_10_1186_s12893_025_02833_9 crossref_primary_10_1093_ndt_gfw304 crossref_primary_10_1016_j_jceh_2017_05_209 crossref_primary_10_1111_ctr_12328 crossref_primary_10_1097_TP_0000000000001385 crossref_primary_10_1111_bjh_14083 crossref_primary_10_1097_TP_0b013e3181ff1458 crossref_primary_10_1016_S1769_7255_08_74238_X crossref_primary_10_23876_j_krcp_19_047 crossref_primary_10_6002_ect_2011_0206 crossref_primary_10_3389_ti_2024_13220 crossref_primary_10_1200_JCO_2012_45_6376 crossref_primary_10_1016_j_acuroe_2020_09_009 crossref_primary_10_1016_j_semnephrol_2024_151494 crossref_primary_10_1186_s12936_018_2206_8 crossref_primary_10_34067_KID_0000000000000545 crossref_primary_10_1007_s00423_018_1694_x crossref_primary_10_1111_iju_15588 crossref_primary_10_1093_ndt_gfac337 crossref_primary_10_1111_bju_12562 crossref_primary_10_1007_s00345_014_1412_4 crossref_primary_10_1158_1055_9965_EPI_09_1220 crossref_primary_10_1002_jhbp_12002 crossref_primary_10_1186_s12882_022_02796_6 crossref_primary_10_1053_j_seminoncol_2014_12_029 crossref_primary_10_6002_ect_2022_0087 crossref_primary_10_1002_ijc_32299 crossref_primary_10_1016_j_mcna_2016_01_006 crossref_primary_10_1002_ijc_24439 crossref_primary_10_1097_MOT_0b013e32830c93ae crossref_primary_10_1097_TP_0000000000002378 crossref_primary_10_1080_14712598_2022_2013799 crossref_primary_10_1080_2162402X_2020_1848068 crossref_primary_10_3389_fimmu_2022_901273 crossref_primary_10_1111_ajt_13978 crossref_primary_10_1111_j_1463_1318_2010_02491_x crossref_primary_10_1111_j_1600_6143_2012_04209_x crossref_primary_10_1016_j_pop_2008_03_003 crossref_primary_10_1016_j_mcna_2023_03_008 crossref_primary_10_1515_med_2020_0118 crossref_primary_10_1016_j_transproceed_2011_01_111 crossref_primary_10_1007_s00467_013_2622_5 crossref_primary_10_3390_jcm10163530 crossref_primary_10_1111_ajt_12234 crossref_primary_10_1016_S1762_0945_08_25189_2 crossref_primary_10_1038_s41581_018_0022_6 crossref_primary_10_1177_2040620715616544 crossref_primary_10_1371_journal_pone_0155179 crossref_primary_10_1016_j_biopha_2011_11_008 crossref_primary_10_1053_j_semnuclmed_2020_12_009 crossref_primary_10_1371_journal_pone_0155602 crossref_primary_10_1111_ctr_12894 crossref_primary_10_1097_TP_0b013e3181b9d918 crossref_primary_10_1111_ctr_12094 crossref_primary_10_1177_2050313X221087567 crossref_primary_10_1111_j_1399_3062_2010_00506_x crossref_primary_10_1111_ajt_15056 crossref_primary_10_1007_s00384_021_03860_7 crossref_primary_10_1007_s42399_025_01793_8 crossref_primary_10_1038_jid_2012_132 crossref_primary_10_1016_j_piel_2022_08_007 crossref_primary_10_1111_ajt_12587 crossref_primary_10_1111_j_1600_6143_2012_04302_x crossref_primary_10_1111_ajt_16825 crossref_primary_10_17650_1726_9776_2019_15_3_120_124 crossref_primary_10_1007_s12094_020_02318_6 crossref_primary_10_1016_j_leukres_2017_03_003 crossref_primary_10_1186_1471_2369_14_137 crossref_primary_10_1016_j_trre_2013_12_002 crossref_primary_10_1111_ajt_15292 crossref_primary_10_1016_S0140_6736_07_61050_2 crossref_primary_10_1155_2012_978930 crossref_primary_10_1111_j_1600_6143_2010_03181_x crossref_primary_10_18632_oncotarget_18890 crossref_primary_10_1097_COH_0b013e328319bcd1 crossref_primary_10_1111_j_1432_2277_2011_01270_x crossref_primary_10_1111_jdv_15538 crossref_primary_10_3389_fcell_2022_956334 crossref_primary_10_1111_j_1440_1797_2011_01549_x crossref_primary_10_5833_jjgs_2015_0155 crossref_primary_10_1111_ajt_13549 crossref_primary_10_1007_s40620_014_0103_y crossref_primary_10_1002_iju5_12438 crossref_primary_10_3390_jcm13164790 crossref_primary_10_3892_mco_2016_952 crossref_primary_10_1186_1471_2407_11_133 crossref_primary_10_3390_cancers14020389 crossref_primary_10_1681_ASN_2018090906 crossref_primary_10_1002_jso_24495 crossref_primary_10_1093_ndt_gfy262 crossref_primary_10_1097_TP_0b013e31816a105b crossref_primary_10_1053_j_ajkd_2007_04_007 crossref_primary_10_1093_ndt_gfp331 crossref_primary_10_1038_modpathol_2013_240 crossref_primary_10_1111_ajt_14181 crossref_primary_10_1111_tri_12484 crossref_primary_10_15825_1995_1191_2017_4_16_26 crossref_primary_10_1002_lt_21634 crossref_primary_10_1111_j_1600_6143_2011_03704_x crossref_primary_10_18632_oncotarget_26859 crossref_primary_10_1016_j_trre_2021_100625 crossref_primary_10_1097_TP_0b013e318193886e crossref_primary_10_1186_s40697_015_0054_9 crossref_primary_10_1002_ijc_27765 crossref_primary_10_1093_jnci_djp236 crossref_primary_10_1016_j_acuro_2020_09_014 crossref_primary_10_1016_j_semnephrol_2022_01_003 crossref_primary_10_1016_j_transproceed_2015_06_009 crossref_primary_10_1177_1758835919876196 crossref_primary_10_1186_s12885_019_6283_z crossref_primary_10_1016_j_purol_2020_04_027 crossref_primary_10_1093_ckj_sfx122 crossref_primary_10_1016_j_prp_2015_04_009 crossref_primary_10_1186_1477_7819_9_72 crossref_primary_10_1016_j_transproceed_2018_12_007 crossref_primary_10_1002_ijc_32565 crossref_primary_10_1002_iju5_12651 crossref_primary_10_1016_j_semnephrol_2016_05_013 crossref_primary_10_1097_TP_0b013e3181a238f6 crossref_primary_10_1016_j_oraloncology_2014_11_007 crossref_primary_10_1186_2047_1440_3_10 crossref_primary_10_1007_s12032_014_0032_6 crossref_primary_10_1007_s13277_016_5148_1 crossref_primary_10_1002_ajh_23726 crossref_primary_10_1016_j_suc_2018_09_004 crossref_primary_10_1038_leu_2011_224 crossref_primary_10_1111_j_1464_410X_2011_10777_x crossref_primary_10_1016_j_trim_2012_06_002 crossref_primary_10_1097_TP_0b013e3181837761 crossref_primary_10_3349_ymj_2011_52_3_454 crossref_primary_10_1007_s12156_007_0013_5 crossref_primary_10_1016_j_biopha_2012_06_001 crossref_primary_10_1177_8756479317705838 crossref_primary_10_1186_2047_1440_2_15 crossref_primary_10_1002_ijc_34875 crossref_primary_10_1186_1471_2407_9_294 crossref_primary_10_1111_j_1600_6143_2008_02385_x crossref_primary_10_1016_j_transproceed_2018_07_031 crossref_primary_10_1158_1940_6207_CAPR_12_0218 crossref_primary_10_1111_j_1600_6143_2007_01908_x crossref_primary_10_1586_14737140_8_8_1339 crossref_primary_10_1097_TP_0000000000001428 crossref_primary_10_1182_blood_2009_02_202507 crossref_primary_10_1038_s41598_019_53163_9 crossref_primary_10_1097_TP_0000000000001201 crossref_primary_10_2217_imt_2021_0195 crossref_primary_10_1097_TP_0000000000000115 crossref_primary_10_1097_TP_0000000000001447 crossref_primary_10_1016_j_canep_2011_12_002 crossref_primary_10_1016_j_transproceed_2014_06_075 crossref_primary_10_1136_lupus_2016_000156 crossref_primary_10_1002_cncr_28043 crossref_primary_10_1093_ndt_gfr277 crossref_primary_10_1186_s12894_023_01389_1 crossref_primary_10_1097_TP_0b013e3182782f59 crossref_primary_10_1038_s41598_020_78283_5 crossref_primary_10_1111_bjh_15790 crossref_primary_10_1002_lt_21554 crossref_primary_10_1093_ndt_gft218 crossref_primary_10_1097_MNH_0000000000000652 crossref_primary_10_1093_ndt_gfad261 crossref_primary_10_1016_j_jaad_2015_05_042 crossref_primary_10_1684_bdc_2012_1545 crossref_primary_10_1016_j_juro_2009_06_043 crossref_primary_10_1038_jid_2008_397 crossref_primary_10_6002_ect_25Liver_L49 crossref_primary_10_1016_j_trre_2007_12_004 crossref_primary_10_1016_j_cgh_2013_12_018 |
Cites_doi | 10.1111/j.1432-2277.2000.tb02068.x 10.1111/j.1365-2133.2005.07021.x 10.1001/jama.294.12.1476 10.1503/cmaj.1040373 10.1038/sj.bjc.6602346 10.1001/jama.296.23.2823 10.1093/ndt/10.supp1.74 10.1016/S0140-6736(73)93256-X 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O 10.1016/S0140-6736(00)02298-4 10.1093/oxfordjournals.aje.a114668 10.1681/ASN.V11suppl_1s1 10.1056/NEJM199912023412303 10.1016/j.jclinepi.2006.07.002 10.1038/sj.bjc.6601219 10.1002/(SICI)1097-0215(19970516)71:4<517::AID-IJC3>3.0.CO;2-X 10.1111/j.1445-2197.2005.03311.x 10.1097/00007890-200011270-00015 10.1136/bmj.2.6203.1461 10.1038/ki.1996.307 10.1111/j.1432-2277.1994.tb01389.x |
ContentType | Journal Article |
Copyright | 2007 INIST-CNRS |
Copyright_xml | – notice: 2007 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7U1 C1K 7X8 |
DOI | 10.1111/j.1600-6143.2007.01736.x |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Risk Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Risk Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Risk Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1600-6143 |
EndPage | 948 |
ExternalDocumentID | 17331115 18701504 10_1111_j_1600_6143_2007_01736_x AJT1736 |
Genre | article Research Support, Non-U.S. Gov't Multicenter Study Journal Article |
GeographicLocations | Canada North America America |
GeographicLocations_xml | – name: Canada |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OC 23M 2WC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAFWJ AALRI AAMMB AAONW AASGY AAXRX AAXUO AAYWO AAZKR ABCQN ABCUV ABEML ABJNI ABPPZ ABPVW ABXGK ACAHQ ACCZN ACGFO ACGFS ACMXC ACPOU ACPRK ACSCC ACVFH ACXBN ACXQS ADBBV ADCNI ADEOM ADIZJ ADKYN ADMGS ADOZA ADVLN ADXAS ADZMN AEFGJ AEGXH AEIMD AENEX AEUPX AFBPY AFEBI AFGKR AFJKZ AFPUW AFZJQ AGCQF AGXDD AHMBA AIACR AIAGR AIDQK AIDYY AIGII AITUG AIURR AJAOE AKBMS AKRWK AKYEP ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMRAJ AMYDB APXCP ATUGU AZBYB AZVAB BAFTC BAWUL BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EFKBS EJD EX3 F00 F01 F04 F5P FDB FUBAC G-S G.N GODZA GX1 H.X HF~ HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RX1 SUPJJ TEORI TR2 UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WVDHM WXI XG1 YFH YUY ZZTAW ~IA ~WT AAHHS AAYXX ACCFJ ADZOD AEEZP AEQDE AIWBW AJBDE CITATION IQODW 24P AEUQT AFPWT CGR CUY CVF ECM EIF ESX FIJ IPNFZ NPM WRC 7U1 C1K 7X8 |
ID | FETCH-LOGICAL-c4786-b1a3e5a77fa8245b672f3d93126fdcc014cf250c6c2c0db2d572f05a6b84d0723 |
IEDL.DBID | DR2 |
ISSN | 1600-6135 |
IngestDate | Fri Sep 05 12:39:30 EDT 2025 Thu Sep 04 21:40:01 EDT 2025 Thu Jan 02 22:52:29 EST 2025 Mon Jul 21 09:13:52 EDT 2025 Thu Apr 24 22:59:19 EDT 2025 Tue Jul 01 03:25:09 EDT 2025 Wed Aug 20 07:27:18 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Kidney disease Graft(material) Urinary system disease Treatment Surgery Kidney cancer Graft Transplantation Malignant tumor Homotransplantation Epidemiology Incidence |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4786-b1a3e5a77fa8245b672f3d93126fdcc014cf250c6c2c0db2d572f05a6b84d0723 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://www.amjtransplant.org/article/S1600613522146654/pdf |
PMID | 17331115 |
PQID | 20422625 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_70308735 proquest_miscellaneous_20422625 pubmed_primary_17331115 pascalfrancis_primary_18701504 crossref_primary_10_1111_j_1600_6143_2007_01736_x crossref_citationtrail_10_1111_j_1600_6143_2007_01736_x wiley_primary_10_1111_j_1600_6143_2007_01736_x_AJT1736 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | April 2007 |
PublicationDateYYYYMMDD | 2007-04-01 |
PublicationDate_xml | – month: 04 year: 2007 text: April 2007 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: United States |
PublicationTitle | American journal of transplantation |
PublicationTitleAlternate | Am J Transplant |
PublicationYear | 2007 |
Publisher | Blackwell Publishing Ltd Blackwell |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell |
References | 1993; 25 2005; 294 2000; 355 1993; 84 1987; 126 1995; 10 2006; 59 1998 1996; 50 1999; 341 1997 2006; 154 1996 2000; 70 2006; 296 2005 2004 1993 1990; 81 1985; 39 1997; 71 2004; 170 1991; 23 2000; 13 1999; 18 1999; 160 2000; 11 1987 1986 2005; 75 1979; 2 2005; 92 1973; 2 1994; 7 2003; 89 1994; 6 Kyllonen (10.1111/j.1600-6143.2007.01736.x_bib11) 2000; 13 Moloney (10.1111/j.1600-6143.2007.01736.x_bib19) 2006; 154 10.1111/j.1600-6143.2007.01736.x_bib25 Kyllonen (10.1111/j.1600-6143.2007.01736.x_bib21) 1994; 7 Goldberg (10.1111/j.1600-6143.2007.01736.x_bib27) 1993; 84 Laupacis (10.1111/j.1600-6143.2007.01736.x_bib4) 1996; 50 Hoshida (10.1111/j.1600-6143.2007.01736.x_bib13) 1997; 71 Wolfe (10.1111/j.1600-6143.2007.01736.x_bib5) 1999; 341 Schnatter (10.1111/j.1600-6143.2007.01736.x_bib26) 1990; 81 Adami (10.1111/j.1600-6143.2007.01736.x_bib8) 2003; 89 Kinlen (10.1111/j.1600-6143.2007.01736.x_bib16) 1979; 2 Chapman (10.1111/j.1600-6143.2007.01736.x_bib14) 2004 Kasiske (10.1111/j.1600-6143.2007.01736.x_bib39) 2000; 11 Chapman (10.1111/j.1600-6143.2007.01736.x_bib20) 2004 Pond (10.1111/j.1600-6143.2007.01736.x_bib12) 2005; 75 Preston (10.1111/j.1600-6143.2007.01736.x_bib30) 1996 Serraino (10.1111/j.1600-6143.2007.01736.x_bib35) 2005; 92 Sheil (10.1111/j.1600-6143.2007.01736.x_bib7) 1993; 25 Breslow (10.1111/j.1600-6143.2007.01736.x_bib37) 1987; Volume 2 Vajdic (10.1111/j.1600-6143.2007.01736.x_bib22) 2006; 296 Copleston (10.1111/j.1600-6143.2007.01736.x_bib24) 1994; 6 Schaubel (10.1111/j.1600-6143.2007.01736.x_bib1) 1999; 160 Parsons (10.1111/j.1600-6143.2007.01736.x_bib3) 1998 Chauhan (10.1111/j.1600-6143.2007.01736.x_bib2) 2004; 170 Kantor (10.1111/j.1600-6143.2007.01736.x_bib10) 1987; 126 Parkin (10.1111/j.1600-6143.2007.01736.x_bib29) 1997 Breslow (10.1111/j.1600-6143.2007.01736.x_bib31) 1987 (10.1111/j.1600-6143.2007.01736.x_bib23) 2005 Gooley (10.1111/j.1600-6143.2007.01736.x_bib33) 1999; 18 Brunner (10.1111/j.1600-6143.2007.01736.x_bib9) 1995; 10 Naldi (10.1111/j.1600-6143.2007.01736.x_bib34) 2000; 70 Southern (10.1111/j.1600-6143.2007.01736.x_bib32) 2006; 59 Penn (10.1111/j.1600-6143.2007.01736.x_bib38) 1991; 23 Hoover (10.1111/j.1600-6143.2007.01736.x_bib15) 1973; 2 Blohme (10.1111/j.1600-6143.2007.01736.x_bib18) 1985; 39 Band (10.1111/j.1600-6143.2007.01736.x_bib28) 1993 Rothman (10.1111/j.1600-6143.2007.01736.x_bib36) 1986 Hampton (10.1111/j.1600-6143.2007.01736.x_bib6) 2005; 294 Birkeland (10.1111/j.1600-6143.2007.01736.x_bib17) 2000; 355 |
References_xml | – volume: 25 start-page: 1383 year: 1993 end-page: 1384 article-title: De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation publication-title: Transplant Proc – volume: 296 start-page: 2823 year: 2006 end-page: 2831 article-title: Cancer incidence before and after kidney transplantation publication-title: JAMA – volume: 341 start-page: 1725 year: 1999 end-page: 1730 article-title: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant publication-title: N Engl J Med – volume: 89 start-page: 1221 year: 2003 end-page: 1227 article-title: Cancer risk following organ transplantation: A nationwide cohort study in Sweden publication-title: Br J Cancer – volume: 70 start-page: 1479 year: 2000 end-page: 1484 article-title: Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry‐based study publication-title: Transplantation – volume: 170 start-page: 1087 year: 2004 article-title: End‐stage renal disease patients up nearly 19% publication-title: Cmaj – year: 2005 – volume: 11 start-page: S1 issue: Suppl 15 year: 2000 end-page: S86 article-title: Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation publication-title: J Am Soc Nephrol – volume: 71 start-page: 517 year: 1997 end-page: 520 article-title: Cancer risk after renal transplantation in Japan publication-title: Int J Cancer – year: 1987 – volume: 23 start-page: 1101 year: 1991 end-page: 1103 article-title: The changing pattern of posttransplant malignancies publication-title: Transplant Proc – year: 1996 – volume: 154 start-page: 498 year: 2006 end-page: 504 article-title: A population‐based study of skin cancer incidence and prevalence in renal transplant recipients publication-title: Br J Dermatol – start-page: 97 year: 1998 end-page: 106 article-title: An update of the Canadian Organ Replacement Register (1998) publication-title: Clin Transpl – volume: 81 start-page: 60 year: 1990 end-page: 65 article-title: An analysis of death ascertainment and follow‐up through statistics Canada's Mortality Data Base system publication-title: Can J Public Health – volume: 2 start-page: 1461 year: 1979 end-page: 1466 article-title: Collaborative United Kingdom‐Australasian study of cancer in patients treated with immunosuppressive drugs publication-title: Br Med J – volume: 294 start-page: 1476 year: 2005 end-page: 1480 article-title: Skin cancer's ranks rise: Immunosuppression to blame publication-title: JAMA – volume: 92 start-page: 572 year: 2005 end-page: 575 article-title: Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients publication-title: Br J Cancer – year: 1986 – volume: 13 start-page: S394 issue: Suppl 1 year: 2000 end-page: 398 article-title: Cancer incidence in a kidney‐transplanted population publication-title: Transpl Int – volume: 355 start-page: 1886 year: 2000 end-page: 1887 article-title: Cancer risk in patients on dialysis and after renal transplantation publication-title: Lancet – volume: 160 start-page: 1557 year: 1999 end-page: 1563 article-title: End‐stage renal disease in Canada: Prevalence projections to 2005 publication-title: CMAJ – volume: 126 start-page: 370 year: 1987 end-page: 376 article-title: Cancer in patients receiving long‐term dialysis treatment publication-title: Am J Epidemiol – volume: 50 start-page: 235 year: 1996 end-page: 242 article-title: A study of the quality of life and cost‐utility of renal transplantation publication-title: Kidney Int – year: 2004 – year: 1997 – volume: 84 start-page: 201 year: 1993 end-page: 204 article-title: The accuracy of ascertaining vital status in a historical cohort study of synthetic textiles workers using computerized record linkage to the Canadian Mortality Data Base publication-title: Can J Public Health – volume: 10 start-page: 74 issue: Suppl 1 year: 1995 end-page: 80 article-title: Malignancies after renal transplantation: The EDTA‐ERA registry experience. European Dialysis and Transplantation Association‐European Renal Association publication-title: Nephrol Dial Transplant – volume: 59 start-page: 1110 year: 2006 end-page: 1114 article-title: Kaplan‐Meier methods yielded misleading results in competing risk scenarios publication-title: J Clin Epidemiol – volume: 7 start-page: S350 issue: Suppl 1 year: 1994 end-page: 352 article-title: Cancer incidence in a kidney‐transplanted population publication-title: Transpl Int – volume: 2 start-page: 55 year: 1973 end-page: 57 article-title: Risk of cancer in renal‐transplant recipients publication-title: Lancet – volume: 39 start-page: 23 year: 1985 end-page: 25 article-title: Malignant disease in renal transplant patients publication-title: Transplantation – volume: 18 start-page: 695 year: 1999 end-page: 706 article-title: Estimation of failure probabilities in the presence of competing risks: New representations of old estimators publication-title: Stat Med – year: 1993 – volume: 6 start-page: 457 year: 1994 end-page: 468 article-title: The Canadian Organ Replacement Register publication-title: Health Rep – volume: 75 start-page: 106 year: 2005 end-page: 109 article-title: Thyroid cancer in the renal transplant population: Epidemiological study publication-title: ANZ J Surg – volume: 160 start-page: 1557 year: 1999 ident: 10.1111/j.1600-6143.2007.01736.x_bib1 article-title: End-stage renal disease in Canada: Prevalence projections to 2005 publication-title: CMAJ – volume: 13 start-page: S394 issue: Suppl 1 year: 2000 ident: 10.1111/j.1600-6143.2007.01736.x_bib11 article-title: Cancer incidence in a kidney-transplanted population publication-title: Transpl Int doi: 10.1111/j.1432-2277.2000.tb02068.x – volume: 154 start-page: 498 year: 2006 ident: 10.1111/j.1600-6143.2007.01736.x_bib19 article-title: A population-based study of skin cancer incidence and prevalence in renal transplant recipients publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2005.07021.x – volume: 294 start-page: 1476 year: 2005 ident: 10.1111/j.1600-6143.2007.01736.x_bib6 article-title: Skin cancer’s ranks rise: Immunosuppression to blame publication-title: JAMA doi: 10.1001/jama.294.12.1476 – year: 1993 ident: 10.1111/j.1600-6143.2007.01736.x_bib28 – volume: 170 start-page: 1087 year: 2004 ident: 10.1111/j.1600-6143.2007.01736.x_bib2 article-title: End-stage renal disease patients up nearly 19% publication-title: Cmaj doi: 10.1503/cmaj.1040373 – start-page: 97 year: 1998 ident: 10.1111/j.1600-6143.2007.01736.x_bib3 article-title: An update of the Canadian Organ Replacement Register (1998) publication-title: Clin Transpl – year: 2004 ident: 10.1111/j.1600-6143.2007.01736.x_bib14 – volume: 92 start-page: 572 year: 2005 ident: 10.1111/j.1600-6143.2007.01736.x_bib35 article-title: Risk of Kaposi’s sarcoma and of other cancers in Italian renal transplant patients publication-title: Br J Cancer doi: 10.1038/sj.bjc.6602346 – volume: 296 start-page: 2823 year: 2006 ident: 10.1111/j.1600-6143.2007.01736.x_bib22 article-title: Cancer incidence before and after kidney transplantation publication-title: JAMA doi: 10.1001/jama.296.23.2823 – volume: 10 start-page: 74 issue: Suppl 1 year: 1995 ident: 10.1111/j.1600-6143.2007.01736.x_bib9 article-title: Malignancies after renal transplantation: The EDTA-ERA registry experience. European Dialysis and Transplantation Association-European Renal Association publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/10.supp1.74 – year: 2004 ident: 10.1111/j.1600-6143.2007.01736.x_bib20 article-title: Chapter 10. Cancer Report – volume: Volume 2 year: 1987 ident: 10.1111/j.1600-6143.2007.01736.x_bib37 article-title: Statistical Methods in Cancer Research publication-title: The Design and Analysis of Cohort StudiesLyon,France :IARC – volume: 81 start-page: 60 year: 1990 ident: 10.1111/j.1600-6143.2007.01736.x_bib26 article-title: An analysis of death ascertainment and follow-up through statistics Canada’s Mortality Data Base system publication-title: Can J Public Health – volume: 2 start-page: 55 year: 1973 ident: 10.1111/j.1600-6143.2007.01736.x_bib15 article-title: Risk of cancer in renal-transplant recipients publication-title: Lancet doi: 10.1016/S0140-6736(73)93256-X – volume: 18 start-page: 695 year: 1999 ident: 10.1111/j.1600-6143.2007.01736.x_bib33 article-title: Estimation of failure probabilities in the presence of competing risks: New representations of old estimators publication-title: Stat Med doi: 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O – volume: 6 start-page: 457 year: 1994 ident: 10.1111/j.1600-6143.2007.01736.x_bib24 article-title: The Canadian Organ Replacement Register publication-title: Health Rep – volume: 25 start-page: 1383 year: 1993 ident: 10.1111/j.1600-6143.2007.01736.x_bib7 article-title: De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation publication-title: Transplant Proc – year: 1987 ident: 10.1111/j.1600-6143.2007.01736.x_bib31 article-title: Statistical methods in cancer research. Volume 2 - The design and analysis of cohort studies – ident: 10.1111/j.1600-6143.2007.01736.x_bib25 – year: 1996 ident: 10.1111/j.1600-6143.2007.01736.x_bib30 – volume: 84 start-page: 201 year: 1993 ident: 10.1111/j.1600-6143.2007.01736.x_bib27 article-title: The accuracy of ascertaining vital status in a historical cohort study of synthetic textiles workers using computerized record linkage to the Canadian Mortality Data Base publication-title: Can J Public Health – volume: 355 start-page: 1886 year: 2000 ident: 10.1111/j.1600-6143.2007.01736.x_bib17 article-title: Cancer risk in patients on dialysis and after renal transplantation publication-title: Lancet doi: 10.1016/S0140-6736(00)02298-4 – volume: 126 start-page: 370 year: 1987 ident: 10.1111/j.1600-6143.2007.01736.x_bib10 article-title: Cancer in patients receiving long-term dialysis treatment publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a114668 – volume: 11 start-page: S1 issue: Suppl 15 year: 2000 ident: 10.1111/j.1600-6143.2007.01736.x_bib39 article-title: Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation publication-title: J Am Soc Nephrol doi: 10.1681/ASN.V11suppl_1s1 – volume: 341 start-page: 1725 year: 1999 ident: 10.1111/j.1600-6143.2007.01736.x_bib5 article-title: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant publication-title: N Engl J Med doi: 10.1056/NEJM199912023412303 – volume: 59 start-page: 1110 year: 2006 ident: 10.1111/j.1600-6143.2007.01736.x_bib32 article-title: Kaplan-Meier methods yielded misleading results in competing risk scenarios publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2006.07.002 – volume: 89 start-page: 1221 year: 2003 ident: 10.1111/j.1600-6143.2007.01736.x_bib8 article-title: Cancer risk following organ transplantation: A nationwide cohort study in Sweden publication-title: Br J Cancer doi: 10.1038/sj.bjc.6601219 – volume: 71 start-page: 517 year: 1997 ident: 10.1111/j.1600-6143.2007.01736.x_bib13 article-title: Cancer risk after renal transplantation in Japan publication-title: Int J Cancer doi: 10.1002/(SICI)1097-0215(19970516)71:4<517::AID-IJC3>3.0.CO;2-X – year: 2005 ident: 10.1111/j.1600-6143.2007.01736.x_bib23 – volume: 75 start-page: 106 year: 2005 ident: 10.1111/j.1600-6143.2007.01736.x_bib12 article-title: Thyroid cancer in the renal transplant population: Epidemiological study publication-title: ANZ J Surg doi: 10.1111/j.1445-2197.2005.03311.x – volume: 70 start-page: 1479 year: 2000 ident: 10.1111/j.1600-6143.2007.01736.x_bib34 article-title: Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study publication-title: Transplantation doi: 10.1097/00007890-200011270-00015 – year: 1986 ident: 10.1111/j.1600-6143.2007.01736.x_bib36 – volume: 2 start-page: 1461 year: 1979 ident: 10.1111/j.1600-6143.2007.01736.x_bib16 article-title: Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs publication-title: Br Med J doi: 10.1136/bmj.2.6203.1461 – volume: 39 start-page: 23 year: 1985 ident: 10.1111/j.1600-6143.2007.01736.x_bib18 article-title: Malignant disease in renal transplant patients publication-title: Transplantation – volume: 50 start-page: 235 year: 1996 ident: 10.1111/j.1600-6143.2007.01736.x_bib4 article-title: A study of the quality of life and cost-utility of renal transplantation publication-title: Kidney Int doi: 10.1038/ki.1996.307 – volume: 23 start-page: 1101 year: 1991 ident: 10.1111/j.1600-6143.2007.01736.x_bib38 article-title: The changing pattern of posttransplant malignancies publication-title: Transplant Proc – volume: 7 start-page: S350 issue: Suppl 1 year: 1994 ident: 10.1111/j.1600-6143.2007.01736.x_bib21 article-title: Cancer incidence in a kidney-transplanted population publication-title: Transpl Int doi: 10.1111/j.1432-2277.1994.tb01389.x – year: 1997 ident: 10.1111/j.1600-6143.2007.01736.x_bib29 |
SSID | ssj0017282 |
Score | 2.3577075 |
Snippet | A number of studies have observed increased cancer incidence rates among individuals who have received renal transplants. Generally, however, these studies... |
SourceID | proquest pubmed pascalfrancis crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 941 |
SubjectTerms | Adolescent Adult Aged Biological and medical sciences Canada Child Databases, Factual Epidemiology Female Follow-Up Studies General aspects Humans Kidney Failure, Chronic - epidemiology Kidney Failure, Chronic - surgery Kidney Failure, Chronic - therapy Kidney Transplantation - adverse effects Kidney Transplantation - statistics & numerical data Kidneys Male Medical sciences Middle Aged Neoplasms - epidemiology Neoplasms - mortality Nephrology. Urinary tract diseases Postoperative Complications - epidemiology Prevalence Public health. Hygiene Public health. Hygiene-occupational medicine Registries Renal Replacement Therapy - statistics & numerical data Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Survival Analysis Tumors of the urinary system |
Title | Cancer Incidence Among Canadian Kidney Transplant Recipients |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1600-6143.2007.01736.x https://www.ncbi.nlm.nih.gov/pubmed/17331115 https://www.proquest.com/docview/20422625 https://www.proquest.com/docview/70308735 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSwMxEA7SkyA-8FWfe_C6pdm8tuCl-KBU8CAWelvyWijKttgW1F_vzGZbXakg4m0PmbDJZDLfJJNvCLlwTniB1-o5ozZGivM49U7EWqWcMWNE25bZFveyN-D9oRhW-U_4FibwQywP3NAyyv0aDVybad3IwVlD6MNZxURIFZMtxJOUSaTRv35YMklhFaby4jOIMFFP6lnZUc1TbUz0FCYtD9UuVsHROrot3dPtFnlaDCxkpTy15jPTsu_fOB__Z-TbZLNCsVE3LLsdsuaLXXJ5hSvoJYItJ1QqjbpYyShaECBEdyNX-Lco8Kk_g0ojAK2jCb7InO6Rwe3N41UvroozxJarVMaGauaFVirXacKFkSrJmeswmsjcWQuRl80BXllpE9t2JnECGrSFliblrq0Stk8axbjwhyRiQnGfQ-AIXpRTjulZRtPEd7iRuaadJlELRWS2Yi7HAhrP2ZcIBmYkwxnBupoqK2cke20SupScBPaOX8ic1XT9KQhbG8Bn3iTnC-VnYIt4waILP55PoRt8l5yIn1uokoGRQYuDsGo-e8fimQDPm0SWuv_1_2bd_iN-Hf1V8JishwNrTEc6IY3Zy9yfAtKambPShj4Ad7EWTQ |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSwMxEA6iBwXxga_63IPXLd3NawteilpqrT1IBW9LXgtiWYttQf31zmy21RUFEW89ZEI3k0m-SSbfR8iptdxxvFbPaGRCpDgPE2d5qGTCKNWaN0xRbdEXnTvWvef3pRwQvoXx_BDzAzeMjGK9xgDHA-lqlMNuDbkPoyUVYSSpqAOgXGKAOzATu7idc0mhDlNx9eltKK-W9XzbU2WvWh2pMQxb5vUuvgOkVXxbbFDtdTKcfZqvS3msTye6bt6-sD7-07dvkLUSyAYtP_M2yYLLt8jZOU6i5wBWHS9WGrRQzCiYcSAE1w82d6-Bp1QfglcDwK0PI3yUOd4md-3LwXknLPUZQsNkIkIdKeq4kjJTScy4FjLOqG3SKBaZNQaSL5MBwjLCxKZhdWw5NGhwJXTCbEPGdIcs5k-52yMB5ZK5DHJH2EhZxLBCS6sodk2mRaaiZo3ImSdSU5KXo4bGMP2UxMCIpDgiKK0p02JE0pcaieaWI0_g8Qub44qzPwxhdQMEzWrkZOb9FMIR71hU7p6mY-gGnybH_OcWsiBhpNBi10-bj95RPxMQeo2Iwvm__r9pqzvAX_t_NTwhy53BTS_tXfWvD8iKP7_G6qRDsjh5nrojAF4TfVwE1Dv6Khps |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSwMxEA6iIIL4wFd97sHrlu7mtQUvRS1aRUQUvC15gihrsS2ov96ZzbZ1RUHE2x4yYZPJZL5JJt8Qcmgtdxyv1T1NTIwU53HmLI-VzBilWvOWKbMtrsTZHevd8_sq_wnfwgR-iMmBG1pGuV-jgfetrxs5OGsIfRitmAgTSUUT8OQcEwAsECDdTKiksAxTefMZZCivZ_V821PNVS321QBmzYdyF9_h0Tq8Lf1Td5k8jkcW0lIem6Ohbpr3L6SP_zP0FbJUwdioE9bdKplxxRo5OsYl9BLBnhNKlUYdLGUUjRkQoosHW7i3KBCqP4FOI0CtD318kjlYJ3fd09vjs7iqzhAbJjMR60RRx5WUXmUp41rI1FPbpkkqvDUGQi_jAV8ZYVLTsjq1HBq0uBI6Y7YlU7pBZovnwm2RiHLJnIfIEdwoSxjmZ2mVpK7NtPAqaTeIHCsiNxV1OVbQeMo_hTAwIznOCBbWlHk5I_lrgyQTyX6g7_iFzH5N11NB2NsAP7MGORgrPwdjxBsWVbjn0QC6wYfJKf-5hSwpGCm02AyrZto7Vs8EfN4gotT9r_837_Ru8Wv7r4IHZP76pJtfnl9d7JCFcHiNqUm7ZHb4MnJ7gLqGer80pw99PRkb |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cancer+Incidence+Among+Canadian+Kidney+Transplant+Recipients&rft.jtitle=American+journal+of+transplantation&rft.au=Villeneuve%2C+PJ&rft.au=Schaubel%2C+DE&rft.au=Fenton%2C+SS&rft.au=Shepherd%2C+FA&rft.date=2007-04-01&rft.issn=1600-6135&rft.volume=7&rft.issue=4&rft.spage=941&rft.epage=948&rft_id=info:doi/10.1111%2Fj.1600-6143.2007.01736.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1600_6143_2007_01736_x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1600-6135&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1600-6135&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1600-6135&client=summon |